Bioresorbable vascular scaffold implantation for the treatment of coronary in-stent restenosis: Results from a multicenter Italian experience

被引：32

作者：

Moscarella, Elisabetta ^{[1
,2
]}

Varricchio, Attilio ^{[1
]}

Stabile, Eugenio ^{[3
]}

Latib, Azeem ^{[4
,5
]}

Ielasi, Alfonso ^{[6
]}

Tespili, Maurizio ^{[6
]}

Cortese, Bernardo ^{[7
]}

Calabro, Paolo ^{[2
]}

Granata, Francesco ^{[1
,2
]}

Panoulas, Vasileios F. ^{[5
]}

Franzone, Anna ^{[3
]}

Trimarco, Bruno ^{[3
]}

Bonzani, Giulio ^{[1
]}

Esposito, Giovanni ^{[3
]}

Colombo, Antonio ^{[4
,5
]}

机构：

[1] Azienda Osped Dei Colli, Presidio Osped Monaldi, Dept Cardiol, Lab Invas Cardiol, Naples, Italy

[2] Univ Naples 2, Azienda Osped Dei Colli, Presidio Osped Monaldi, Lab Invas Cardiol,Dept Cardiol, Naples, Italy

[3] Univ Naples Federico II, Dipartimento Sci Biomed Avanzate, Lab Invas Cardiol, Naples, Italy

[4] EMO GVM Ctr Cuore Columbus, UO Emodinam & Cardiol Interventist, Milan, Italy

[5] Univ Milan, Osped San Raffaele, I-20127 Milan, Italy

[6] UOC Cardiol, Azienda Osped Bolognini Seriate, Bergamo, Italy

[7] Azienda Osped Fatebenefratelli, Lab Invas Cardiol, Milan, Italy

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 2015年 / 199卷

关键词：

BVS; Restenosis; DES; Stent; DRUG-ELUTING STENTS; BALLOON ANGIOPLASTY; RANDOMIZED-TRIAL;

D O I：

10.1016/j.ijcard.2015.07.002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This multicenter experience sought to investigate the feasibility and safety of BVS for the treatment of ISR. From April 2012 to June 2014, a total of 315 patients (334 lesions) underwent PCI for ISR at the participating centers. Of those, 83 patients (90 lesions) received BVS. Procedural success was achieved in all patients. At a median of 7 (IQR 3-18) months follow-up, MACCE rate was 12%, TLR 7.7%, while one (1.1%) definite BVS-in-stent thrombosis was reported. The results of this multicenter experience suggest that BVS implantation for the treatment of coronary ISR is technically feasible and associated with favorable mid-term clinical results. These data could be considered hypothesis generating for a future randomized clinical trial. (C) 2015 Elsevier Ireland Ltd. All rights reserved.

引用

页码：366 / 372

页数：7

共 50 条

[1] Long term clinical outcome following Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-stent Restenosis: a Multicenter Italian Experience
Moscarella, Elisabetta
Varricchio, Attilio
Granata, Francesco
Coscarelli, Sebastian
Stabile, Eugenio
Latib, Azeem
Ielasi, Alfonso
Cortese, Bernardo
Tespili, Maurizio
Calabro, Paolo
Tanaka, Akihito
Capozzolo, Claudia
Colombo, Antonio
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (15) : B211 - B211
[2] Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis A Multicenter Italian Experience
Moscarella, Elisabetta
Ielasi, Alfonso
Granata, Francesco
Coscarelli, Sebastian
Stabile, Eugenio
Latib, Azeem
Cortese, Bernardo
Tespili, Maurizio
Tanaka, Akihito
Capozzolo, Claudia
Caliendo, Luigi
Colombo, Antonio
Varricchio, Attilio
[J]. CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (04)
[3] Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary in Stent Restenosis: Long-term Clinical Outcomes of a Multicenter Italian Experience
Moscarella, Elisabetta
Ielasi, Alfonso
De Angelis, Maria Carmen
Cortese, Bernardo
Coscarelli, Sebastian
Tanaka, Akihito
Latib, Azeem
Tespili, Maurizio
Varricchio, Attilio
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (16) : S31 - S31
[4] Coronary artery aneurysm formation following implantation of a bioresorbable vascular scaffold for in-stent restenosis
Garcia-Guimaraes, Marcos
Cuesta, Javier
Alvarado, Teresa
Rivero, Fernando
Bastante, Teresa
Benedicto, Amparo
Alfonso, Fernando
[J]. REVISTA PORTUGUESA DE CARDIOLOGIA, 2017, 36 (06)
[5] Early results following everolimus-eluting bioresorbable vascular scaffold implantation for the treatment of in-stent restenosis
Ielasi, Alfonso
Latib, Azeem
Naganuma, Toru
Cortese, Bernardo
Sato, Katsumasa
Miyazaki, Tadashi
Panoulas, Vasileios F.
Tespili, Maurizio
Colombo, Antonio
[J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 173 (03) : 513 - 514
[6] Bioresorbable vascular scaffold implantation for treatment of recurrent in-stent restenosis: Insights from optical coherence tomography
Camuglia, Anthony C.
Lavi, Shahar
[J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 172 (01) : 238 - 239
[7] Bioresorbable vascular scaffold for the treatment of coronary in-stent restenosis: New dawn or frost on snow?
Ge, Junbo
[J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2018, 92 (04) : 678 - 679
[8] Recurrent Neoatherosclerosis After Bioresorbable Vascular Scaffold Treatment of In-Stent Restenosis
Bastante, Teresa
Rivero, Fernando
Benedicto, Amparo
Cuesta, Javier
Alfonso, Fernando
[J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (09) : 1264 - 1265
[9] Bioresorbable Vascular Scaffold Use in a Case of In-stent Restenosis
Cadrin-Tourigny, Julia
Dong, Liang
Maehara, Akiko
Schampaert, Erick
Genereux, Philippe
[J]. ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2014, 103 (01) : E11 - E14
[10] Bioresorbable vascular scaffold to treat in-stent restenosis: Single-center experience
Picard, Fabien
Avram, Robert
Marquis-Gravel, Guillaume
Tadros, Victor-Xavier
Ly, Hung Q.
de Hemptinne, Quentin
Dorval, Jean-Francois
L'allier, Philippe L.
Tanguay, Jean-Francois
[J]. JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2017, 30 (06) : 558 - 563

← 1 2 3 4 5 →